Individuals vaccinated against seasonal influenza in the seven major markets (7MM) are expected to rise from 270 million in 2022 to 284 million in 2032, showing a yearly growth rate of 0.5%, reveals GlobalData, a prominent data and analytics company.
GlobalData’s most recent report, “Epidemiology Forecast to 2032 for Seasonal Influenza Vaccines,” predicts that by 2032, the United States will lead the 7MM with more than 171 million vaccinated individuals, while Spain is expected to have the lowest number, with approximately 11.6 million vaccinated individuals. GlobalData’s estimates indicate that in 2032, the 5EU will have a total of 78 million vaccinated individuals.
Seasonal Influenza’s Disproportionate Impact on Children
Seasonal influenza impacts people of all age groups, but it particularly affects young children and the elderly, who are more susceptible to infections due to either underdeveloped or weakened immune systems or underlying chronic conditions.
The number of seasonal influenza cases varies annually and is influenced by fluctuations in influenza epidemics and vaccination initiatives in each market. Targeted vaccination programs, especially for the elderly and vulnerable populations, help alleviate the severity of infections and reduce the strain on healthcare systems.
Dr. Bhandari concludes, “Seasonal influenza shares respiratory symptoms with COVID-19, making accurate diagnosis and treatment a challenge. This underscores the importance of taking precautions to reduce transmission and promote vaccination, especially among the elderly and clinically vulnerable populations for both influenza and COVID-19.”
Source: Medindia
